{"title":"TREM1变异对中国汉族胶质瘤风险和预后的影响","authors":"Mingjun Hu, Jie Wei, Jie Hao, Tianbo Jin, Bin Li","doi":"10.2147/PGPM.S403870","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Glioma is the main pathological subtype of brain tumors with high mortality.</p><p><strong>Objective: </strong>This study aimed to elucidate the correlation between <i>TREM1</i> variants and glioma risk in the Chinese Han population.</p><p><strong>Methods: </strong>Genotyping of six variants of <i>TREM1</i> was completed by Agena MassARRAY platform in 1061 subjects (503 controls and 558 glioma patients). The relationship between <i>TREM1</i> polymorphisms and glioma risk was calculated using the logistic regression model, with odds ratio (OR) and 95% confidence intervals (CIs). A multifactor dimensionality reduction (MDR) method was performed to assess SNP-SNP interactions to predict glioma risk.</p><p><strong>Results: </strong>In this research, overall analysis illustrated an association between <i>TREM1</i> rs9369269 and an increased risk of glioma. Rs9369269 was also related to the risk of glioma in patients aged ≤40 years and females. Subjects with rs9369269 AC genotype were likely to obtain glioma compared to people with CC genotype (patients with astroglioma vs healthy people). Compared to TT genotype carriers, carriers with AT genotype of rs1351835 were significantly associated with overall survival (OS).</p><p><strong>Conclusion: </strong>Taken together, the study identified the association between <i>TREM1</i> variants and glioma risk and <i>TREM1</i> variants were significantly associated with the prognosis of glioma. In the future, larger samples are needed to verify the results.</p>","PeriodicalId":56015,"journal":{"name":"Pharmacogenomics & Personalized Medicine","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/1d/pgpm-16-707.PMC10327902.pdf","citationCount":"0","resultStr":"{\"title\":\"Impact of <i>TREM1</i> Variants on the Risk and Prognosis of Glioma in the Chinese Han Population.\",\"authors\":\"Mingjun Hu, Jie Wei, Jie Hao, Tianbo Jin, Bin Li\",\"doi\":\"10.2147/PGPM.S403870\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Glioma is the main pathological subtype of brain tumors with high mortality.</p><p><strong>Objective: </strong>This study aimed to elucidate the correlation between <i>TREM1</i> variants and glioma risk in the Chinese Han population.</p><p><strong>Methods: </strong>Genotyping of six variants of <i>TREM1</i> was completed by Agena MassARRAY platform in 1061 subjects (503 controls and 558 glioma patients). The relationship between <i>TREM1</i> polymorphisms and glioma risk was calculated using the logistic regression model, with odds ratio (OR) and 95% confidence intervals (CIs). A multifactor dimensionality reduction (MDR) method was performed to assess SNP-SNP interactions to predict glioma risk.</p><p><strong>Results: </strong>In this research, overall analysis illustrated an association between <i>TREM1</i> rs9369269 and an increased risk of glioma. Rs9369269 was also related to the risk of glioma in patients aged ≤40 years and females. Subjects with rs9369269 AC genotype were likely to obtain glioma compared to people with CC genotype (patients with astroglioma vs healthy people). Compared to TT genotype carriers, carriers with AT genotype of rs1351835 were significantly associated with overall survival (OS).</p><p><strong>Conclusion: </strong>Taken together, the study identified the association between <i>TREM1</i> variants and glioma risk and <i>TREM1</i> variants were significantly associated with the prognosis of glioma. In the future, larger samples are needed to verify the results.</p>\",\"PeriodicalId\":56015,\"journal\":{\"name\":\"Pharmacogenomics & Personalized Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/1d/pgpm-16-707.PMC10327902.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacogenomics & Personalized Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/PGPM.S403870\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics & Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PGPM.S403870","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Impact of TREM1 Variants on the Risk and Prognosis of Glioma in the Chinese Han Population.
Background: Glioma is the main pathological subtype of brain tumors with high mortality.
Objective: This study aimed to elucidate the correlation between TREM1 variants and glioma risk in the Chinese Han population.
Methods: Genotyping of six variants of TREM1 was completed by Agena MassARRAY platform in 1061 subjects (503 controls and 558 glioma patients). The relationship between TREM1 polymorphisms and glioma risk was calculated using the logistic regression model, with odds ratio (OR) and 95% confidence intervals (CIs). A multifactor dimensionality reduction (MDR) method was performed to assess SNP-SNP interactions to predict glioma risk.
Results: In this research, overall analysis illustrated an association between TREM1 rs9369269 and an increased risk of glioma. Rs9369269 was also related to the risk of glioma in patients aged ≤40 years and females. Subjects with rs9369269 AC genotype were likely to obtain glioma compared to people with CC genotype (patients with astroglioma vs healthy people). Compared to TT genotype carriers, carriers with AT genotype of rs1351835 were significantly associated with overall survival (OS).
Conclusion: Taken together, the study identified the association between TREM1 variants and glioma risk and TREM1 variants were significantly associated with the prognosis of glioma. In the future, larger samples are needed to verify the results.
期刊介绍：
Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.
In particular, emphasis will be given to:
Genomic and proteomic profiling
Genetics and drug metabolism
Targeted drug identification and discovery
Optimizing drug selection & dosage based on patient''s genetic profile
Drug related morbidity & mortality intervention
Advanced disease screening and targeted therapeutic intervention
Genetic based vaccine development
Patient satisfaction and preference
Health economic evaluations
Practical and organizational issues in the development and implementation of personalized medicine programs.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
